Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 258430, 4 pages
http://dx.doi.org/10.1155/2015/258430
Research Article

Possible Triggering Effect of Influenza Vaccination on Psoriasis

Department of Dermatology, Faculty of Medicine, Dokuz Eylul University, Inciraltı, 35340 Izmir, Turkey

Received 22 October 2014; Accepted 23 March 2015

Academic Editor: L. Leite

Copyright © 2015 Ali Tahsin Gunes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-F. Rahier, M. Moutschen, A. van Gompel et al., “Vaccinations in patients with immune-mediated inflammatory diseases,” Rheumatology, vol. 49, no. 10, pp. 1815–1827, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Shoenfeld and A. Aron-Maor, “Vaccination and autoimmunity—‘vaccinosis’: a dangerous liaison?” Journal of Autoimmunity, vol. 14, no. 1, pp. 1–10, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Orbach, N. Agmon-Levin, and G. Zandman-Goddard, “Vaccines and autoimmune diseases of the adult,” Discovery Medicine, vol. 9, no. 45, pp. 90–97, 2010. View at Google Scholar · View at Scopus
  4. S. Salemi and R. D'Amelio, “Could autoimmunity be induced by vaccination,” International Reviews of Immunology, vol. 29, no. 3, pp. 247–269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Ganzetti, A. Campanati, A. Santarelli et al., “Involvement of the oral cavity in psoriasis: results of a clinical study,” The British Journal of Dermatology, vol. 172, no. 1, pp. 282–285, 2015. View at Publisher · View at Google Scholar
  6. M. A. Lowes, M. Suárez-Fariñas, and J. G. Krueger, “Immunology of psoriasis,” Annual Review of Immunology, vol. 32, pp. 227–255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Valdimarsson, R. H. Thorleifsdottir, S. L. Sigurdardottir, J. E. Gudjonsson, and A. Johnston, “Psoriasis—as an autoimmune disease caused by molecular mimicry,” Trends in Immunology, vol. 30, no. 10, pp. 494–501, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Fry and B. S. Baker, “Triggering psoriasis: the role of infections and medications,” Clinics in Dermatology, vol. 25, no. 6, pp. 606–615, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. E. Griffiths and J. N. Barker, “Pathogenesis and clinical features of psoriasis,” The Lancet, vol. 370, no. 9583, pp. 263–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Raaschou-Nielsen, “Psoriasis vaccinalis; report of two cases, one following B.C.G. vaccination and one following vaccination against influenza,” Acta Dermato-Venereologica, vol. 35, no. 1, pp. 37–42, 1955. View at Google Scholar
  11. R. Koca, H. C. Altinyazar, G. Numanoğlu, and M. Ünalacak, “Guttate psoriasis-like lesions following BCG vaccination,” Journal of Tropical Pediatrics, vol. 50, no. 3, pp. 178–179, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Takayama, T. Satoh, M. Hayashi, and H. Yokozeki, “Psoriatic skin lesions induced by BCG vaccination,” Acta Dermato-Venereologica, vol. 88, no. 6, pp. 621–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Dudelzak, A. R. Curtis, D. J. Sheehan, and J. L. Lesher Jr., “New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy,” Journal of Drugs in Dermatology, vol. 7, no. 7, p. 684, 2008. View at Google Scholar · View at Scopus
  14. V. C. Macias and D. Cunha, “Psoriasis triggered by tetanus-diphtheria vaccination,” Cutaneous and Ocular Toxicology, vol. 32, no. 2, pp. 164–165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Pattison, B. J. Harrison, C. E. M. Griffiths, A. J. Silman, and I. N. Bruce, “Environmental risk factors for the development of psoriatic arthritis: results from a case-control study,” Annals of the Rheumatic Diseases, vol. 67, no. 5, pp. 672–676, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. S. Shin, S. J. Kim, S. H. Kim, Y. G. Kwak, and H.-J. Park, “New onset guttate psoriasis following pandemic H1N1 influenza vaccination,” Annals of Dermatology, vol. 25, no. 4, pp. 489–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Sbidian, P. Eftekahri, M. Viguier et al., “National Survey of Psoriasis flares after 2009 monovalent H1N1/seasonal vaccines,” Dermatology, vol. 229, no. 2, 2014. View at Publisher · View at Google Scholar
  18. A. B. Kimball, D. Gladman, J. M. Gelfand et al., “National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening,” Journal of the American Academy of Dermatology, vol. 58, no. 6, pp. 1031–1042, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Sbidian, F. Tubach, B. Pasquet et al., “Factors associated with 2009 monovalent H1N1 vaccine coverage: a cross sectional study of 1308 patients with psoriasis in France,” Vaccine, vol. 30, no. 39, pp. 5703–5707, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Wine-Lee, S. C. Keller, M. B. Wilck, S. J. Gluckman, and A. S. Van Voorhees, “From the medical board of the national psoriasis foundation: vaccination in adult patients on systemic therapy for psoriasis,” Journal of the American Academy of Dermatology, vol. 69, no. 6, pp. 1003–1013, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Cerpa-Cruz, P. Paredes-Casillas, E. L. Navarro, A. G. Bernard-Medina, G. Martínez-Bonilla, and S. Gutiérrez-Ureña, “Adverse events following immunization with vaccines containing adjuvants,” Immunologic Research, vol. 56, no. 2-3, pp. 299–303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. F. Nikkels, N. Nikkels-Tassoudji, and G. E. Piérard, “Cutaneous adverse reactions following anti-infective vaccinations,” The American Journal of Clinical Dermatology, vol. 6, no. 2, pp. 79–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. J. Choe, H. Cho, S. N. Kim, G.-R. Bae, and J.-K. Lee, “Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003–2010,” Vaccine, vol. 29, no. 44, pp. 7727–7732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Perdan-Pirkmajer, G. G. Thallinger, N. Snoj et al., “Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease,” Lupus, vol. 21, no. 2, pp. 175–183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Y. Tsai, N. Q. Hanson, R. J. Straka et al., “Effect of influenza vaccine on markers of inflammation and lipid profile,” Journal of Laboratory and Clinical Medicine, vol. 145, no. 6, pp. 323–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. G. A. Lanza, L. Barone, G. Scalone et al., “Inflammation-related effects of adjuvant influenza A vaccination on platelet activation and cardiac autonomic function,” Journal of Internal Medicine, vol. 269, no. 1, pp. 118–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Hamouda, A. Chepurnov, N. Mank et al., “Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model,” Human Vaccines, vol. 6, no. 7, pp. 585–594, 2010. View at Publisher · View at Google Scholar · View at Scopus